nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Pentagastrin—BCHE—kidney cancer	0.00831	0.609	CrCbGaD
Nafarelin—Desmopressin—PTGS1—kidney cancer	0.00339	0.248	CrCbGaD
Nafarelin—Desmopressin—PTGS2—kidney cancer	0.00194	0.142	CrCbGaD
Nafarelin—Decreased appetite—Erlotinib—kidney cancer	0.00109	0.0011	CcSEcCtD
Nafarelin—Dizziness—Pazopanib—kidney cancer	0.00109	0.0011	CcSEcCtD
Nafarelin—Oedema—Sunitinib—kidney cancer	0.00109	0.0011	CcSEcCtD
Nafarelin—Alopecia—Gemcitabine—kidney cancer	0.00108	0.0011	CcSEcCtD
Nafarelin—Pulmonary embolism—Doxorubicin—kidney cancer	0.00108	0.0011	CcSEcCtD
Nafarelin—Epistaxis—Paclitaxel—kidney cancer	0.00108	0.00109	CcSEcCtD
Nafarelin—Gastritis—Capecitabine—kidney cancer	0.00108	0.00109	CcSEcCtD
Nafarelin—Anorexia—Sorafenib—kidney cancer	0.00108	0.00109	CcSEcCtD
Nafarelin—Muscular weakness—Capecitabine—kidney cancer	0.00107	0.00109	CcSEcCtD
Nafarelin—Sinusitis—Paclitaxel—kidney cancer	0.00107	0.00109	CcSEcCtD
Nafarelin—Constipation—Erlotinib—kidney cancer	0.00107	0.00109	CcSEcCtD
Nafarelin—Myalgia—Dactinomycin—kidney cancer	0.00107	0.00109	CcSEcCtD
Nafarelin—Shock—Sunitinib—kidney cancer	0.00107	0.00108	CcSEcCtD
Nafarelin—Abdominal distension—Capecitabine—kidney cancer	0.00106	0.00107	CcSEcCtD
Nafarelin—Cystitis noninfective—Doxorubicin—kidney cancer	0.00106	0.00107	CcSEcCtD
Nafarelin—Vomiting—Pazopanib—kidney cancer	0.00105	0.00106	CcSEcCtD
Nafarelin—Cystitis—Doxorubicin—kidney cancer	0.00104	0.00106	CcSEcCtD
Nafarelin—Rash—Pazopanib—kidney cancer	0.00104	0.00105	CcSEcCtD
Nafarelin—Nausea—Temsirolimus—kidney cancer	0.00104	0.00105	CcSEcCtD
Nafarelin—Dermatitis—Pazopanib—kidney cancer	0.00104	0.00105	CcSEcCtD
Nafarelin—Anorexia—Sunitinib—kidney cancer	0.00103	0.00105	CcSEcCtD
Nafarelin—Headache—Pazopanib—kidney cancer	0.00103	0.00105	CcSEcCtD
Nafarelin—Rhinitis—Paclitaxel—kidney cancer	0.00103	0.00104	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00103	0.00104	CcSEcCtD
Nafarelin—Oedema—Dactinomycin—kidney cancer	0.00103	0.00104	CcSEcCtD
Nafarelin—Sweating increased—Capecitabine—kidney cancer	0.00102	0.00104	CcSEcCtD
Nafarelin—Vertigo—Vincristine—kidney cancer	0.00101	0.00102	CcSEcCtD
Nafarelin—Dyspnoea—Sorafenib—kidney cancer	0.00101	0.00102	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000989	0.001	CcSEcCtD
Nafarelin—Dysuria—Capecitabine—kidney cancer	0.000984	0.000997	CcSEcCtD
Nafarelin—Rash maculo-papular—Doxorubicin—kidney cancer	0.000983	0.000996	CcSEcCtD
Nafarelin—Insomnia—Sunitinib—kidney cancer	0.000982	0.000995	CcSEcCtD
Nafarelin—Decreased appetite—Sorafenib—kidney cancer	0.00098	0.000994	CcSEcCtD
Nafarelin—Anorexia—Dactinomycin—kidney cancer	0.000979	0.000993	CcSEcCtD
Nafarelin—Nausea—Pazopanib—kidney cancer	0.000977	0.000991	CcSEcCtD
Nafarelin—Neoplasm—Doxorubicin—kidney cancer	0.000977	0.000991	CcSEcCtD
Nafarelin—Bladder pain—Doxorubicin—kidney cancer	0.000977	0.000991	CcSEcCtD
Nafarelin—Paraesthesia—Sunitinib—kidney cancer	0.000974	0.000988	CcSEcCtD
Nafarelin—Convulsion—Vincristine—kidney cancer	0.000974	0.000988	CcSEcCtD
Nafarelin—Dyspnoea—Sunitinib—kidney cancer	0.000968	0.000981	CcSEcCtD
Nafarelin—Constipation—Sorafenib—kidney cancer	0.000964	0.000978	CcSEcCtD
Nafarelin—Myalgia—Vincristine—kidney cancer	0.000958	0.000971	CcSEcCtD
Nafarelin—Weight increased—Capecitabine—kidney cancer	0.000957	0.000971	CcSEcCtD
Nafarelin—Weight decreased—Capecitabine—kidney cancer	0.000952	0.000965	CcSEcCtD
Nafarelin—Decreased appetite—Sunitinib—kidney cancer	0.000943	0.000956	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000936	0.000949	CcSEcCtD
Nafarelin—Asthenia—Vinblastine—kidney cancer	0.000936	0.000949	CcSEcCtD
Nafarelin—Depression—Capecitabine—kidney cancer	0.000935	0.000948	CcSEcCtD
Nafarelin—Asthenia—Everolimus—kidney cancer	0.000932	0.000945	CcSEcCtD
Nafarelin—Constipation—Sunitinib—kidney cancer	0.000928	0.000941	CcSEcCtD
Nafarelin—Acute coronary syndrome—Capecitabine—kidney cancer	0.000925	0.000938	CcSEcCtD
Nafarelin—Myocardial infarction—Capecitabine—kidney cancer	0.00092	0.000932	CcSEcCtD
Nafarelin—Pruritus—Everolimus—kidney cancer	0.000919	0.000932	CcSEcCtD
Nafarelin—Oedema—Vincristine—kidney cancer	0.000918	0.000931	CcSEcCtD
Nafarelin—Conjunctivitis—Capecitabine—kidney cancer	0.000912	0.000924	CcSEcCtD
Nafarelin—Arthralgia—Gemcitabine—kidney cancer	0.000908	0.000921	CcSEcCtD
Nafarelin—Myalgia—Gemcitabine—kidney cancer	0.000908	0.000921	CcSEcCtD
Nafarelin—Chest pain—Gemcitabine—kidney cancer	0.000908	0.000921	CcSEcCtD
Nafarelin—Alopecia—Paclitaxel—kidney cancer	0.000907	0.000919	CcSEcCtD
Nafarelin—Asthenia—Erlotinib—kidney cancer	0.000899	0.000912	CcSEcCtD
Nafarelin—Mental disorder—Paclitaxel—kidney cancer	0.000899	0.000911	CcSEcCtD
Nafarelin—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000898	0.00091	CcSEcCtD
Nafarelin—Urticaria—Sorafenib—kidney cancer	0.000896	0.000908	CcSEcCtD
Nafarelin—Malnutrition—Paclitaxel—kidney cancer	0.000893	0.000906	CcSEcCtD
Nafarelin—Decreased appetite—Dactinomycin—kidney cancer	0.000893	0.000905	CcSEcCtD
Nafarelin—Diarrhoea—Vinblastine—kidney cancer	0.000892	0.000905	CcSEcCtD
Nafarelin—Diarrhoea—Everolimus—kidney cancer	0.000889	0.000901	CcSEcCtD
Nafarelin—Hyperhidrosis—Vincristine—kidney cancer	0.000887	0.0009	CcSEcCtD
Nafarelin—Pruritus—Erlotinib—kidney cancer	0.000887	0.000899	CcSEcCtD
Nafarelin—Epistaxis—Capecitabine—kidney cancer	0.000885	0.000897	CcSEcCtD
Nafarelin—Tension—Paclitaxel—kidney cancer	0.000877	0.000889	CcSEcCtD
Nafarelin—Anorexia—Vincristine—kidney cancer	0.000875	0.000887	CcSEcCtD
Nafarelin—Dysgeusia—Paclitaxel—kidney cancer	0.000875	0.000887	CcSEcCtD
Nafarelin—Oedema—Gemcitabine—kidney cancer	0.000871	0.000883	CcSEcCtD
Nafarelin—Eye pain—Doxorubicin—kidney cancer	0.000869	0.000881	CcSEcCtD
Nafarelin—Nervousness—Paclitaxel—kidney cancer	0.000868	0.00088	CcSEcCtD
Nafarelin—Dizziness—Vinblastine—kidney cancer	0.000862	0.000874	CcSEcCtD
Nafarelin—Dizziness—Everolimus—kidney cancer	0.000859	0.000871	CcSEcCtD
Nafarelin—Diarrhoea—Erlotinib—kidney cancer	0.000858	0.00087	CcSEcCtD
Nafarelin—Rhinitis—Capecitabine—kidney cancer	0.000844	0.000856	CcSEcCtD
Nafarelin—Hyperhidrosis—Gemcitabine—kidney cancer	0.000842	0.000853	CcSEcCtD
Nafarelin—Hot flush—Doxorubicin—kidney cancer	0.000839	0.00085	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000836	0.000848	CcSEcCtD
Nafarelin—Increased appetite—Doxorubicin—kidney cancer	0.000835	0.000847	CcSEcCtD
Nafarelin—Menopausal symptoms—Doxorubicin—kidney cancer	0.000832	0.000843	CcSEcCtD
Nafarelin—Insomnia—Vincristine—kidney cancer	0.00083	0.000842	CcSEcCtD
Nafarelin—Anorexia—Gemcitabine—kidney cancer	0.00083	0.000842	CcSEcCtD
Nafarelin—Vomiting—Vinblastine—kidney cancer	0.000829	0.000841	CcSEcCtD
Nafarelin—Dizziness—Erlotinib—kidney cancer	0.000829	0.00084	CcSEcCtD
Nafarelin—Vomiting—Everolimus—kidney cancer	0.000826	0.000838	CcSEcCtD
Nafarelin—Paraesthesia—Vincristine—kidney cancer	0.000824	0.000836	CcSEcCtD
Nafarelin—Rash—Everolimus—kidney cancer	0.000819	0.000831	CcSEcCtD
Nafarelin—Dermatitis—Everolimus—kidney cancer	0.000818	0.00083	CcSEcCtD
Nafarelin—Headache—Vinblastine—kidney cancer	0.000817	0.000828	CcSEcCtD
Nafarelin—Headache—Everolimus—kidney cancer	0.000814	0.000825	CcSEcCtD
Nafarelin—Asthenia—Sorafenib—kidney cancer	0.000809	0.00082	CcSEcCtD
Nafarelin—Vertigo—Paclitaxel—kidney cancer	0.000803	0.000814	CcSEcCtD
Nafarelin—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000801	0.000812	CcSEcCtD
Nafarelin—Decreased appetite—Vincristine—kidney cancer	0.000798	0.000809	CcSEcCtD
Nafarelin—Pruritus—Sorafenib—kidney cancer	0.000798	0.000809	CcSEcCtD
Nafarelin—Vomiting—Erlotinib—kidney cancer	0.000797	0.000808	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000793	0.000804	CcSEcCtD
Nafarelin—Rash—Erlotinib—kidney cancer	0.00079	0.000801	CcSEcCtD
Nafarelin—Dermatitis—Erlotinib—kidney cancer	0.00079	0.000801	CcSEcCtD
Nafarelin—Palpitations—Paclitaxel—kidney cancer	0.000789	0.0008	CcSEcCtD
Nafarelin—Insomnia—Gemcitabine—kidney cancer	0.000788	0.000798	CcSEcCtD
Nafarelin—Headache—Erlotinib—kidney cancer	0.000785	0.000796	CcSEcCtD
Nafarelin—Constipation—Vincristine—kidney cancer	0.000785	0.000796	CcSEcCtD
Nafarelin—Paraesthesia—Gemcitabine—kidney cancer	0.000782	0.000793	CcSEcCtD
Nafarelin—Asthenia—Sunitinib—kidney cancer	0.000779	0.000789	CcSEcCtD
Nafarelin—Dyspnoea—Gemcitabine—kidney cancer	0.000776	0.000787	CcSEcCtD
Nafarelin—Nausea—Vinblastine—kidney cancer	0.000775	0.000785	CcSEcCtD
Nafarelin—Convulsion—Paclitaxel—kidney cancer	0.000774	0.000785	CcSEcCtD
Nafarelin—Affect lability—Doxorubicin—kidney cancer	0.000772	0.000783	CcSEcCtD
Nafarelin—Nausea—Everolimus—kidney cancer	0.000772	0.000782	CcSEcCtD
Nafarelin—Diarrhoea—Sorafenib—kidney cancer	0.000772	0.000782	CcSEcCtD
Nafarelin—Pruritus—Sunitinib—kidney cancer	0.000768	0.000778	CcSEcCtD
Nafarelin—Chest pain—Paclitaxel—kidney cancer	0.000761	0.000771	CcSEcCtD
Nafarelin—Myalgia—Paclitaxel—kidney cancer	0.000761	0.000771	CcSEcCtD
Nafarelin—Arthralgia—Paclitaxel—kidney cancer	0.000761	0.000771	CcSEcCtD
Nafarelin—Decreased appetite—Gemcitabine—kidney cancer	0.000757	0.000767	CcSEcCtD
Nafarelin—Dizziness—Sorafenib—kidney cancer	0.000746	0.000756	CcSEcCtD
Nafarelin—Constipation—Gemcitabine—kidney cancer	0.000745	0.000755	CcSEcCtD
Nafarelin—Nausea—Erlotinib—kidney cancer	0.000745	0.000755	CcSEcCtD
Nafarelin—Alopecia—Capecitabine—kidney cancer	0.000744	0.000754	CcSEcCtD
Nafarelin—Mood swings—Doxorubicin—kidney cancer	0.000743	0.000754	CcSEcCtD
Nafarelin—Diarrhoea—Sunitinib—kidney cancer	0.000743	0.000753	CcSEcCtD
Nafarelin—Mental disorder—Capecitabine—kidney cancer	0.000738	0.000748	CcSEcCtD
Nafarelin—Asthenia—Dactinomycin—kidney cancer	0.000737	0.000747	CcSEcCtD
Nafarelin—Malnutrition—Capecitabine—kidney cancer	0.000733	0.000743	CcSEcCtD
Nafarelin—Oedema—Paclitaxel—kidney cancer	0.000729	0.000739	CcSEcCtD
Nafarelin—Dry skin—Doxorubicin—kidney cancer	0.000719	0.000729	CcSEcCtD
Nafarelin—Dysgeusia—Capecitabine—kidney cancer	0.000718	0.000728	CcSEcCtD
Nafarelin—Dizziness—Sunitinib—kidney cancer	0.000718	0.000728	CcSEcCtD
Nafarelin—Shock—Paclitaxel—kidney cancer	0.000717	0.000727	CcSEcCtD
Nafarelin—Vomiting—Sorafenib—kidney cancer	0.000717	0.000727	CcSEcCtD
Nafarelin—Rash—Sorafenib—kidney cancer	0.000711	0.000721	CcSEcCtD
Nafarelin—Dermatitis—Sorafenib—kidney cancer	0.00071	0.00072	CcSEcCtD
Nafarelin—Headache—Sorafenib—kidney cancer	0.000707	0.000716	CcSEcCtD
Nafarelin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000705	0.000715	CcSEcCtD
Nafarelin—Diarrhoea—Dactinomycin—kidney cancer	0.000703	0.000713	CcSEcCtD
Nafarelin—Anorexia—Paclitaxel—kidney cancer	0.000695	0.000705	CcSEcCtD
Nafarelin—Gastritis—Doxorubicin—kidney cancer	0.000694	0.000704	CcSEcCtD
Nafarelin—Muscular weakness—Doxorubicin—kidney cancer	0.000692	0.000702	CcSEcCtD
Nafarelin—Vomiting—Sunitinib—kidney cancer	0.00069	0.0007	CcSEcCtD
Nafarelin—Rash—Sunitinib—kidney cancer	0.000684	0.000694	CcSEcCtD
Nafarelin—Dermatitis—Sunitinib—kidney cancer	0.000684	0.000693	CcSEcCtD
Nafarelin—Abdominal distension—Doxorubicin—kidney cancer	0.000683	0.000692	CcSEcCtD
Nafarelin—Headache—Sunitinib—kidney cancer	0.00068	0.000689	CcSEcCtD
Nafarelin—Nausea—Sorafenib—kidney cancer	0.00067	0.000679	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000664	0.000673	CcSEcCtD
Nafarelin—Insomnia—Paclitaxel—kidney cancer	0.000659	0.000669	CcSEcCtD
Nafarelin—Vertigo—Capecitabine—kidney cancer	0.000659	0.000668	CcSEcCtD
Nafarelin—Asthenia—Vincristine—kidney cancer	0.000659	0.000668	CcSEcCtD
Nafarelin—Paraesthesia—Paclitaxel—kidney cancer	0.000655	0.000664	CcSEcCtD
Nafarelin—Vomiting—Dactinomycin—kidney cancer	0.000653	0.000662	CcSEcCtD
Nafarelin—Dyspnoea—Paclitaxel—kidney cancer	0.00065	0.000659	CcSEcCtD
Nafarelin—Palpitations—Capecitabine—kidney cancer	0.000648	0.000657	CcSEcCtD
Nafarelin—Rash—Dactinomycin—kidney cancer	0.000648	0.000657	CcSEcCtD
Nafarelin—Nausea—Sunitinib—kidney cancer	0.000645	0.000654	CcSEcCtD
Nafarelin—Dysuria—Doxorubicin—kidney cancer	0.000634	0.000643	CcSEcCtD
Nafarelin—Decreased appetite—Paclitaxel—kidney cancer	0.000634	0.000643	CcSEcCtD
Nafarelin—Diarrhoea—Vincristine—kidney cancer	0.000628	0.000637	CcSEcCtD
Nafarelin—Asthenia—Gemcitabine—kidney cancer	0.000625	0.000633	CcSEcCtD
Nafarelin—Myalgia—Capecitabine—kidney cancer	0.000624	0.000633	CcSEcCtD
Nafarelin—Chest pain—Capecitabine—kidney cancer	0.000624	0.000633	CcSEcCtD
Nafarelin—Arthralgia—Capecitabine—kidney cancer	0.000624	0.000633	CcSEcCtD
Nafarelin—Constipation—Paclitaxel—kidney cancer	0.000623	0.000632	CcSEcCtD
Nafarelin—Weight increased—Doxorubicin—kidney cancer	0.000617	0.000626	CcSEcCtD
Nafarelin—Pruritus—Gemcitabine—kidney cancer	0.000616	0.000625	CcSEcCtD
Nafarelin—Weight decreased—Doxorubicin—kidney cancer	0.000614	0.000622	CcSEcCtD
Nafarelin—Nausea—Dactinomycin—kidney cancer	0.00061	0.000619	CcSEcCtD
Nafarelin—Dizziness—Vincristine—kidney cancer	0.000607	0.000615	CcSEcCtD
Nafarelin—Oedema—Capecitabine—kidney cancer	0.000598	0.000607	CcSEcCtD
Nafarelin—Diarrhoea—Gemcitabine—kidney cancer	0.000596	0.000604	CcSEcCtD
Nafarelin—Shock—Capecitabine—kidney cancer	0.000589	0.000597	CcSEcCtD
Nafarelin—Conjunctivitis—Doxorubicin—kidney cancer	0.000588	0.000596	CcSEcCtD
Nafarelin—Vomiting—Vincristine—kidney cancer	0.000584	0.000592	CcSEcCtD
Nafarelin—Urticaria—Paclitaxel—kidney cancer	0.000579	0.000587	CcSEcCtD
Nafarelin—Rash—Vincristine—kidney cancer	0.000579	0.000587	CcSEcCtD
Nafarelin—Hyperhidrosis—Capecitabine—kidney cancer	0.000578	0.000586	CcSEcCtD
Nafarelin—Dermatitis—Vincristine—kidney cancer	0.000578	0.000586	CcSEcCtD
Nafarelin—Headache—Vincristine—kidney cancer	0.000575	0.000583	CcSEcCtD
Nafarelin—Epistaxis—Doxorubicin—kidney cancer	0.00057	0.000578	CcSEcCtD
Nafarelin—Anorexia—Capecitabine—kidney cancer	0.00057	0.000578	CcSEcCtD
Nafarelin—Sinusitis—Doxorubicin—kidney cancer	0.000567	0.000575	CcSEcCtD
Nafarelin—Vomiting—Gemcitabine—kidney cancer	0.000554	0.000561	CcSEcCtD
Nafarelin—Rash—Gemcitabine—kidney cancer	0.000549	0.000557	CcSEcCtD
Nafarelin—Dermatitis—Gemcitabine—kidney cancer	0.000549	0.000556	CcSEcCtD
Nafarelin—Headache—Gemcitabine—kidney cancer	0.000546	0.000553	CcSEcCtD
Nafarelin—Nausea—Vincristine—kidney cancer	0.000545	0.000553	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000545	0.000553	CcSEcCtD
Nafarelin—Rhinitis—Doxorubicin—kidney cancer	0.000544	0.000552	CcSEcCtD
Nafarelin—Insomnia—Capecitabine—kidney cancer	0.000541	0.000549	CcSEcCtD
Nafarelin—Paraesthesia—Capecitabine—kidney cancer	0.000537	0.000545	CcSEcCtD
Nafarelin—Dyspnoea—Capecitabine—kidney cancer	0.000533	0.000541	CcSEcCtD
Nafarelin—Asthenia—Paclitaxel—kidney cancer	0.000523	0.00053	CcSEcCtD
Nafarelin—Decreased appetite—Capecitabine—kidney cancer	0.00052	0.000527	CcSEcCtD
Nafarelin—Nausea—Gemcitabine—kidney cancer	0.000517	0.000524	CcSEcCtD
Nafarelin—Pruritus—Paclitaxel—kidney cancer	0.000516	0.000523	CcSEcCtD
Nafarelin—Constipation—Capecitabine—kidney cancer	0.000512	0.000519	CcSEcCtD
Nafarelin—Diarrhoea—Paclitaxel—kidney cancer	0.000499	0.000506	CcSEcCtD
Nafarelin—Dizziness—Paclitaxel—kidney cancer	0.000482	0.000489	CcSEcCtD
Nafarelin—Alopecia—Doxorubicin—kidney cancer	0.00048	0.000486	CcSEcCtD
Nafarelin—Mental disorder—Doxorubicin—kidney cancer	0.000476	0.000482	CcSEcCtD
Nafarelin—Urticaria—Capecitabine—kidney cancer	0.000475	0.000482	CcSEcCtD
Nafarelin—Malnutrition—Doxorubicin—kidney cancer	0.000473	0.000479	CcSEcCtD
Nafarelin—Tension—Doxorubicin—kidney cancer	0.000464	0.00047	CcSEcCtD
Nafarelin—Vomiting—Paclitaxel—kidney cancer	0.000464	0.00047	CcSEcCtD
Nafarelin—Dysgeusia—Doxorubicin—kidney cancer	0.000463	0.000469	CcSEcCtD
Nafarelin—Rash—Paclitaxel—kidney cancer	0.00046	0.000466	CcSEcCtD
Nafarelin—Dermatitis—Paclitaxel—kidney cancer	0.000459	0.000466	CcSEcCtD
Nafarelin—Nervousness—Doxorubicin—kidney cancer	0.000459	0.000465	CcSEcCtD
Nafarelin—Headache—Paclitaxel—kidney cancer	0.000457	0.000463	CcSEcCtD
Nafarelin—Nausea—Paclitaxel—kidney cancer	0.000433	0.000439	CcSEcCtD
Nafarelin—Asthenia—Capecitabine—kidney cancer	0.000429	0.000435	CcSEcCtD
Nafarelin—Vertigo—Doxorubicin—kidney cancer	0.000425	0.00043	CcSEcCtD
Nafarelin—Pruritus—Capecitabine—kidney cancer	0.000423	0.000429	CcSEcCtD
Nafarelin—Palpitations—Doxorubicin—kidney cancer	0.000418	0.000423	CcSEcCtD
Nafarelin—Convulsion—Doxorubicin—kidney cancer	0.000409	0.000415	CcSEcCtD
Nafarelin—Diarrhoea—Capecitabine—kidney cancer	0.000409	0.000415	CcSEcCtD
Nafarelin—Myalgia—Doxorubicin—kidney cancer	0.000402	0.000408	CcSEcCtD
Nafarelin—Chest pain—Doxorubicin—kidney cancer	0.000402	0.000408	CcSEcCtD
Nafarelin—Arthralgia—Doxorubicin—kidney cancer	0.000402	0.000408	CcSEcCtD
Nafarelin—Dizziness—Capecitabine—kidney cancer	0.000396	0.000401	CcSEcCtD
Nafarelin—Oedema—Doxorubicin—kidney cancer	0.000386	0.000391	CcSEcCtD
Nafarelin—Vomiting—Capecitabine—kidney cancer	0.00038	0.000386	CcSEcCtD
Nafarelin—Shock—Doxorubicin—kidney cancer	0.000379	0.000385	CcSEcCtD
Nafarelin—Rash—Capecitabine—kidney cancer	0.000377	0.000382	CcSEcCtD
Nafarelin—Dermatitis—Capecitabine—kidney cancer	0.000377	0.000382	CcSEcCtD
Nafarelin—Headache—Capecitabine—kidney cancer	0.000375	0.00038	CcSEcCtD
Nafarelin—Hyperhidrosis—Doxorubicin—kidney cancer	0.000373	0.000378	CcSEcCtD
Nafarelin—Anorexia—Doxorubicin—kidney cancer	0.000368	0.000373	CcSEcCtD
Nafarelin—Nausea—Capecitabine—kidney cancer	0.000355	0.00036	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000351	0.000356	CcSEcCtD
Nafarelin—Insomnia—Doxorubicin—kidney cancer	0.000349	0.000354	CcSEcCtD
Nafarelin—Paraesthesia—Doxorubicin—kidney cancer	0.000346	0.000351	CcSEcCtD
Nafarelin—Dyspnoea—Doxorubicin—kidney cancer	0.000344	0.000349	CcSEcCtD
Nafarelin—Decreased appetite—Doxorubicin—kidney cancer	0.000335	0.00034	CcSEcCtD
Nafarelin—Constipation—Doxorubicin—kidney cancer	0.00033	0.000334	CcSEcCtD
Nafarelin—Urticaria—Doxorubicin—kidney cancer	0.000306	0.000311	CcSEcCtD
Nafarelin—Asthenia—Doxorubicin—kidney cancer	0.000277	0.000281	CcSEcCtD
Nafarelin—Pruritus—Doxorubicin—kidney cancer	0.000273	0.000277	CcSEcCtD
Nafarelin—Diarrhoea—Doxorubicin—kidney cancer	0.000264	0.000268	CcSEcCtD
Nafarelin—Dizziness—Doxorubicin—kidney cancer	0.000255	0.000259	CcSEcCtD
Nafarelin—Vomiting—Doxorubicin—kidney cancer	0.000245	0.000249	CcSEcCtD
Nafarelin—Rash—Doxorubicin—kidney cancer	0.000243	0.000247	CcSEcCtD
Nafarelin—Dermatitis—Doxorubicin—kidney cancer	0.000243	0.000246	CcSEcCtD
Nafarelin—Headache—Doxorubicin—kidney cancer	0.000242	0.000245	CcSEcCtD
Nafarelin—Nausea—Doxorubicin—kidney cancer	0.000229	0.000232	CcSEcCtD
